Dyspepsia: all 370 studies

Page 3 of 4. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Therapeutic Effect of Ursodeoxycholic Acid in Functional DyspepsiaActive, not recruitingNCT03004118Phase 4
• Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional DyspepsiaCompletedNCT03003234Not applicable
• Acupuncture for Functional Dyspepsia: a Functional Magnetic Resonance Imaging (fMRI) StudyCompletedNCT02996604Not applicable
• Treatment of Constipation in Functional DyspepsiaCompletedNCT02956187Not applicable
• Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal FunctionStatus unknownNCT02928484Phase 1/2
• A Study to Evaluate the Effects of ABX-1431 on Patients With Functional DyspepsiaTerminatedNCT02875678Phase 1
• SIBO, Immune Activation, and FGIDs in ChildrenCompletedNCT02872961
• Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.WithdrawnNCT02863822Not applicable
• Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.Status unknownNCT02831543Phase 3
• Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal SymptomsCompletedNCT02775591Phase 4
• Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.Status unknownNCT02737683
• Physiological Response and Visual Attention to Visual Food Images in Healthy Subjects and in Functional Dyspepsia PatientsCompletedNCT02727556Not applicable
• Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux DiseaseCompletedNCT02685150Not applicable
• Mast Cells in Acid-induced Intestinal PermeabilityTerminatedNCT02664051Phase 4
• Efficacy and Safety of Two Simeticone Brands in Adults With Functional DyspepsiaCompletedNCT02660372Phase 3
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple TherapyCompletedNCT02633930Phase 4
• A Two Week Nitazoxanidebased Quadruple RegimenStatus unknownNCT02621359Phase 3
• Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and GastrinCompletedNCT02620696Phase 1
• Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive ModulationCompletedNCT02618070Not applicable
• Effectiveness of tDCS for the Treatment of Functional DyspepsiaStatus unknownNCT02611414Phase 2/3
• Efficacy of Bromopride and Simethicone Versus Bromopride in Functional DyspepsiaCompletedNCT02604576Phase 3
• Hedonic Perception and Brain Activity Response to MealCompletedNCT02592239Not applicable
• UBT as a Diagnostic Tool for HP PrevalanceStatus unknownNCT02570776
• A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional DyspepsiaTerminatedNCT02567578Phase 2
• Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal DisordersCompletedNCT02566876Phase 4
• fMRI and Visceral Perception Upon Capsaicin InfusionCompletedNCT02551029Not applicable
• Functional Dyspepsia and Symptom PerceptionStatus unknownNCT02522000
• The Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's OesophagusCompletedNCT02498041Not applicable
• Pharmacokinetic Study of LevosulpirideCompletedNCT02481583Phase 1
• Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by EndomicroscopyStatus unknownNCT02465996Not applicable
• The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical StudyCompletedNCT02460601Phase 4
• Effects of Diet on Reflux and DyspepsiaCompletedNCT02425553
• Study of Motilitone to Treat Functional DyspepsiaCompletedNCT02365701Phase 2
• Functional Dyspepsia (FD) - Clinical Response to Montelukast in ChildrenCompletedNCT02360696
• The Effect and Mechanism of Acupuncture on Functional DyspepsiaStatus unknownNCT02358486Not applicable
• Functional Dyspepsia Microbiome StudyCompletedNCT02340312
• Web-based Management of Pediatric Functional Abdominal PainCompletedNCT02327377Not applicable
• Mucosal Impedance in Pediatric PopulationCompletedNCT02320981
• Internet-delivered CBT for Functional Abdominal Pain in Adolescents - a PilotCompletedNCT02306941Not applicable
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT02296021Phase 4
• Effect of Genetic Association With Functional Dyspepsia and Mood DisordersStatus unknownNCT02282995
• Probiotic Supplementation Among Adults With Recurrent Gastrointestinal SymptomsCompletedNCT02277431Phase 2/3
• A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic PainCompletedNCT02197143Phase 4
• Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori EradicationCompletedNCT02175901Phase 4
• Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional DyspepsiaCompletedNCT02173925
• A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional DyspepsiaStatus unknownNCT02162316Not applicable
• SSRI Study for Functional Dyspepsia (SS)CompletedNCT02153567Phase 3
• Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI MethodStatus unknownNCT02151708Not applicable
• Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional DyspepsiaStatus unknownNCT02134405Phase 4
• Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal DisordersCompletedNCT02113605Not applicable
• Gastric Activity and Gastrointestinal Peptides in Patients With Functional DyspepsiaCompletedNCT02113527
• Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing GastroduodenoscopyStatus unknownNCT02105090Phase 4
• Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI MethodCompletedNCT02091635Not applicable
• Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild IndigestionCompletedNCT02051348Phase 2/3
• Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)WithdrawnNCT02039869Not applicable
• HEP-FYN 12-Years Follow-upStatus unknownNCT02001727Not applicable
• Phase III, Long-term, Open-label Safety Study of Z-338CompletedNCT01973790Phase 3
• Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled TrialStatus unknownNCT01921504Not applicable
• Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive ImagingCompletedNCT01919021Not applicable
• High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori EradicationCompletedNCT01888237Phase 4
• Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel ToxicityCompletedNCT01849107Not applicable
• Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly PopulationCompletedNCT01837940Phase 3
• A Study to Demonstrate the Efficacy and Safety of Motilitone®CompletedNCT01817465Phase 4
• Phase 2a Study of IW-9179 to Treat Functional DyspepsiaTerminatedNCT01712412Phase 2
• Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
• Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract SystemCompletedNCT01682798Not applicable
• Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive SystemCompletedNCT01677715Not applicable
• Acupuncture for Patients With Function DyspepsiaCompletedNCT01671670Phase 2/3
• Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic PatientsCompletedNCT01670552Phase 3
• Empirical Rescue Therapies of Helicobacter Pylori InfectionCompletedNCT01668927Phase 4
• Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori TreatmentCompletedNCT01667718Phase 4
• Aizthromycin or Clarithromycin in H-pylori Eradication RegimenCompletedNCT01667692Phase 4
• Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.PyloriCompletedNCT01667575Phase 4
• Rifaximin for Functional DyspepsiaCompletedNCT01643083Phase 2/3
• The Efficacy of Pantoprazole Treatment in Patients With Functional DyspepsiaStatus unknownNCT01608750Phase 4
• Ghrelin and Gastric Emptying in Children With Functional DyspepsiaCompletedNCT01591174
• New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot StudyCompletedNCT01513785Phase 2
• Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on TherapeuticsCompletedNCT01485328Phase 3
• From the Biomedical to the Biopsychosocial Model, From Theory to PracticeStatus unknownNCT01456273Not applicable
• Supplementation With L. Reuteri in H. Pylori Infected AdultsStatus unknownNCT01449500Not applicable
• Use of Maytenus Ilicifolia in the Treatment of DyspepsiaTerminatedNCT01408849Phase 2
• Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During ChemotherapyCompletedNCT01382667
• The Clinical Significance of Acid Rebound in Functional DyspepsiaTerminatedNCT01373970Phase 4
• Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional DyspepsiaWithdrawnNCT01373372Not applicable
• Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional DyspepsiaCompletedNCT01355276Phase 3
• BRAVO Study for Functional DyspepsiaCompletedNCT01349413Phase 4
• Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal PainWithdrawnNCT01269671Phase 1
• Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional DyspepsiaTerminatedNCT01268618Phase 2/3
• Mirtazapine Versus Placebo in Functional DyspepsiaCompletedNCT01240096Phase 4
• Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional DyspepsiaStatus unknownNCT01232114
• Effect Of Itopride On Gastric Emptying And Accommodation In Patients With Functional DyspepsiaStatus unknownNCT01226134Not applicable
• Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled TrialCompletedNCT01205100Not applicable
• Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)TerminatedNCT01199679Not applicable
• The Effect of Oxytocin on Gastric EmptyingCompletedNCT01152047Not applicable
• A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal InjuryCompletedNCT01140828Phase 3
• Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.Status unknownNCT01129713Phase 1/2
• Propofol Versus Midazolam With Fentanyl for EGD EndomicroscopyCompletedNCT01053871Not applicable
• Gabapentin in Functional Dyspepsia Refractory to Proton Pump InhibitionWithdrawnNCT01052896Phase 3
• Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled TrialCompletedNCT01047800Not applicable
• Lansoprazole for Subgroups of Functional DyspepsiaTerminatedNCT01040455Phase 4

← Dyspepsia overview